Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00075855
First received: January 9, 2004
Last updated: February 19, 2012
Last verified: February 2005